Welcome to our dedicated page for DHYRT news (Ticker: DHYRT), a resource for investors and traders seeking the latest updates and insights on DHYRT stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect DHYRT's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of DHYRT's position in the market.
Credit Suisse High Yield Credit Fund (NYSE American: DHY) announced a transferable rights offering for holders of record on April 21, 2026. Each Common Share will receive one Right; three Rights purchase one new share. The Offer is expected to expire on May 14, 2026 and Rights to trade as DHY RT through May 13, 2026. Subscription price equals the higher of 92.5% of five-day average market price or 86.0% of NAV. Proceeds expected to fund senior loans and CLOs; offering expenses borne by the Fund.